Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review
PHAGE: Therapy, Applications, and Research · 01.09.2025 · 6 (3) · 140-153
DOI: 10.1089/phage.2024.0059 ↗Kurz gefasst
Fachartikel in der Zeitschrift PHAGE: Therapy, Applications, and Research, online erschienen am 12.06.2025. Verfasst von Saskia Janssen und 9 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Phage therapy shows promise for treating mycobacterial infections, though clinical trial data on efficacy are still needed. We review preclinical studies assessing the efficacy and safety of phage therapy in mycobacterial diseases, focusing on in vitro , ex vivo , and in vivo models to inform clinical trial design. Most studies addressed Mycobacterium tuberculosis (M. tb) , with phage D29 commonly used. Of all studies reporting activity, 91% (20/22) reported reduced mycobacterial counts. Some phages (4/7 assessed) also demonstrated activity against intracellular mycobacteria. Animal models (seven studies) showed efficacy and safety of four phages assessed, in infection models for M. tb , Mycobacterium ulcerans , Mycobacterium avium , and Mycobacterium abscessus , respectively. Substantial variability in results could be explained by experimental designs used. To advance clinical trials, we recommend standardized preclinical experiments on phage susceptibility, intracellular activity, and sampling from infection sites. This preclinical evidence supports further exploration of phage therapy for mycobacterial infections in clinical trials.
Zitieren
APA
Janssen, S., Larsen, S. E., Morrow, C., Ramsubag, B., Torres, M. P., Bustamante, C. A. G., Coler, R. N., Ingen, J. V., Hatfull, G. F., & Diacon, A. H. (2025). Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review. PHAGE: Therapy, Applications, and Research, 6(3), 140-153. https://doi.org/10.1089/phage.2024.0059
Vancouver
Janssen S, Larsen SE, Morrow C, Ramsubag B, Torres MP, Bustamante CAG, et al. Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review. PHAGE: Therapy, Applications, and Research. 2025;6(3):140-153. doi:10.1089/phage.2024.0059
BibTeX
@article{Janssen2025,
author = {Janssen, Saskia and Larsen, Sasha E. and Morrow, Carl and Ramsubag, Bhavna and Torres, Marta Pozuelo and Bustamante, Carlos A. Guerrero and Coler, Rhea N. and Ingen, Jakko van and Hatfull, Graham F. and Diacon, Andreas H.},
title = {Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review},
journal = {PHAGE: Therapy, Applications, and Research},
year = {2025},
volume = {6},
number = {3},
pages = {140--153},
doi = {10.1089/phage.2024.0059}
}
EUVIMED